Recovery from multiple cranial nerve palsy of Wegener's granulomatosis with infliximab

Journal of Rheumatology

Volumn 35, Issue 7, 2008, Pages 1471-1472

  Fujikawa, Keita ^a   Kawakami, Atsushi ^a   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; INFLIXIMAB; PREDNISOLONE;

ADULT; AUDIOMETRY; CASE REPORT; CRANIAL NERVE PARALYSIS; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FACIAL NERVE PARALYSIS; HUMAN; HYPOGLOSSAL NERVE DISEASE; LETTER; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME; TRIGEMINAL NERVE DISEASE; VAGUS NERVE DISEASE; WEGENER GRANULOMATOSIS;

ADULT; ANTIBODIES, MONOCLONAL; CRANIAL NERVE DISEASES; HEARING LOSS; HUMANS; MALE; RECOVERY OF FUNCTION; TUMOR NECROSIS FACTOR-ALPHA; WEGENER GRANULOMATOSIS;

EID: 47349131316     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Weinberger LM, Cohen ML, Remler BF, et al. Intracranial Wegener's granulomatosis. Neurology 1993;43:1831-4.
2. Nishino H, Rubino F, DeRemee R, et al. Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol 1993;33:4-9.
3. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7.
4. Luqmani RA, Bacon PA, Moots RJ, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994;87:671-8.
5. Reinhold-Keller E, de Groot K, Holl-Ulrich K, et al. Severe CNS manifestations as the clinical hallmark in generalized Wegener's granulomatosis consistently negative for antineutrophil cytoplasmic antibodies (ANCA). A report of 3 cases and a review of the literature. Clin Exp Rheumatol 2001;19:541-9.
6. Mukhtyar C, Luqmani R. Current state of tumor necrosis factor a blockade in Wegener's granulomatosis. Ann Rheum Dis 2005;64:31-6.